HOME >> MEDICINE >> NEWS
Other highlights in the October 15 issue of JNCI

Study Confirms Risk Factors for Malignant Melanoma

A new study confirms previous findings that hair color, number of moles on the legs, and history of sunburn are risk factors for malignant melanoma. The study also found that the use of sunbeds and other tanning devices is associated with an increased risk of the disease. Marit Veierd, Ph.D., of the University of Oslo in Norway, and colleagues surveyed 106,379 Norwegian and Swedish women between the ages of 30 and 50 about their personal characteristics and exposures. During an average follow-up of 8.1 years, there were 187 cases of melanoma diagnosed among these women. Melanoma risk was associated with increasing body surface area; the number of large asymmetric moles on the legs; having naturally red hair; the number of sunburns per year during the second, third, and fourth decades of life; and use one or more times per month of artificial tanning lights. The authors also note that the strongest effects of UV exposure on melanoma risk appear to be during adolescence and early adulthood.

Low White Cell Counts May Affect Breast Cancer Outcomes Among African American Women

African American women with early-stage breast cancer have lower baseline white blood cell counts and therefore appear to have delays in doses of adjuvant chemotherapy compared with white women with early-stage breast cancer. The treatment delays may explain racial differences in breast cancer survival, authors of a new study suggest. Dawn Hershman, M.D., of the New York-Presbyterian Hospital in New York, and her colleagues collected information on 73 African American and 126 matched white women, and of these women, 43 white and 93 African American women had undergone adjuvant chemotherapy. They found that African American women had lower white blood cell counts at baseline and after treatment and required a longer treatment duration (19 weeks versus 15 weeks). "This difference in dose intensity may contribute to t
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Dec-2000


Page: 1 2 3

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Other highlights in the January 19 JNCI
5. Other highlights in the December 15 JNCI
6. Other highlights in the December 1 JNCI
7. Other highlights in the September 15 JNCI
8. Other highlights in the April 21 JNCI
9. Other highlights in the April 7 JNCI
10. Other highlights in the January 7 issue of JNCI
11. Other highlights in the December 3 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... organization behind the New England Journal of Medicine and NEJM Journal Watch, announces ... Pediatrics Board Review was created by a panel of pediatricians from leading medical ...
(Date:3/27/2017)... Orion, Michigan (PRWEB) , ... March 27, 2017 ... ... results. The comprehensive weight management program at Women’s Excellence will help patients ... initial evaluation and physical exam. The specialists at Women's Excellence will measure ...
(Date:3/27/2017)... ... ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from California ... she said. , She thinks the coming week is going to be a very joyful ... to help my students.” , The award will allow the 4th grade teacher at Tumwater ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017  Twist ... high-quality DNA synthesis, today announced that it raised an ... a total of $166 million. "It ... as we expand our reach and continue to deliver ... in multiple market segments," commented Emily M. Leproust, Ph.D., ...
(Date:3/27/2017)...   Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company ... the Company,s Chief Operating Officer, is scheduled to present a corporate ... 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 ... ... 24th Annual Future Leaders in Biotech Industry – Friday, April 7, ...
(Date:3/24/2017)... PORTLAND, Oregon and PUNE, India , March 24, 2017 ... in 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a ... expected to generate the highest revenue, and is projected to dominate the market during ... ... Allied Market Research Logo ...
Breaking Medicine Technology:
Cached News: